LXRX EBITDA | LEXICON PHARMACEUTICALS, INC.

LEXICON PHARMACEUTICALS, INC. (LXRX) EBITDA

2026-06-30: Basis Reported; EBITDA -$26.44M*; Operating income -$26.54M; Depreciation and amortization $102.00K*.
2026-03-31: Basis Reported; EBITDA -$886,000.00; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$14.66M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$12.04M*; Operating income -$12.19M; Depreciation and amortization $151.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$26.44M*	-$26.54M	$102.00K*	(m)	(m)	(m)	-$9.19M*	$39.00K	$17.44M	$9.75M	(m)
2026-03-31	Reported	-$886,000.00	(m)	(m)	(m)	-4.20%	(m)	-$14.73M	$108.00K	$12.76M	$9.23M	(m)
2025-12-31	Reported	-$14.66M	(m)	(m)	(m)	-266.92%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$12.04M*	-$12.19M	$151.00K*	(m)	(m)	$0.00*	-$23.83M*	$10.00K	$18.76M	$7.60M	(m)
2025-06-30	Reported	$3.91M*	$3.74M	$176.00K*	(m)	(m)	(m)	$16.99M*	$33.00K	$15.75M	$9.35M	(m)
2025-03-31	Reported	-$25.5M	(m)	(m)	(m)	-2020.84%	(m)	-$43.78M	$30.00K	$15.30M	$11.61M	(m)
2024-12-31	Reported	-$32.61M	(m)	(m)	(m)	-2104.00%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$63.57M*	-$63.69M	$126.00K*	$1.74M	-3651.18%*	$307.00K*	-$53.62M*	$71.00K	$25.78M	$39.59M	(m)
2024-06-30	Reported	-$55.22M*	-$55.35M	$139.00K*	$1.62M	-3414.66%*	$250.00K*	-$48.54M*	$166.00K	$17.64M	$39.19M	(m)
2024-03-31	Reported	-$45.19M	(m)	(m)	(m)	-4134.40%	$0.00	-$55.13M	$31.00K	$14.37M	$32.06M	(m)
2023-12-31	Reported	-$46.59M	(m)	(m)	(m)	-6933.04%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$49.48M*	-$49.63M	$151.00K*	$148.00K	-33432.43%*	$83.00K*	-$41.62M*	$7.00K	$17.56M	$32.23M	(m)
2023-06-30	Reported	-$44.10M*	-$44.24M	$144.00K*	$291.00K	-15153.26%*	$139.00K*	-$38.12M*	$8.00K	$14.54M	$30.01M	(m)
2023-03-31	Reported	-$31.03M	(m)	(m)	(m)	(m)	$248.00K	-$31.61M	$0.00	$12.03M	$19.14M	(m)
2022-12-31	Reported	-$30.18M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$22.99M*	-$23.09M	$108.00K*	$0.00	(m)	$4.00K*	-$19.44M*	$0.00	$10.56M	$12.58M	(m)
2022-06-30	Reported	-$23.90M*	-$24.01M	$107.00K*	$0.00	(m)	$0.00*	-$24.42M*	$0.00	$13.36M	(m)	(m)
2022-03-31	Reported	-$23.27M	(m)	(m)	(m)	(m)	$76.00K	-$23.42M	(m)	$14.93M	(m)	(m)
2021-12-31	Reported	-$25.22M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$22.86M*	-$22.96M	$101.00K*	$0.00	(m)	$213.00K*	-$17.15M*	$0.00	$15.68M	(m)	(m)
2021-06-30	Reported	-$17.92M*	-$17.96M	$42.00K*	$0.00	(m)	$947.00K*	-$21.88M*	$0.00	$10.26M	(m)	(m)
2021-03-31	Reported	-$20.8M	(m)	(m)	(m)	(m)	$38.00K	-$25.16M	$0.00	$12.61M	(m)	(m)
2020-12-31	Reported	-$7.11M	(m)	(m)	(m)	-30.44%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$87.46M*	$86.67M	$784.00K*	$0.00	(m)	$33.00K*	-$40.38M*	$633.00K	$40.15M	(m)	(m)
2020-06-30	Reported	-$63.68M*	-$64.58M	$900.00K*	$25.00K	-254716.00%*	$0.00*	-$46.30M*	$728.00K	$57.30M	(m)	(m)
2020-03-31	Reported	-$61.53M	(m)	(m)	(m)	-769150.00%	$0.00	-$22.05M	$568.00K	$55.18M	(m)	(m)
2019-12-31	Reported	-$46.28M	(m)	(m)	(m)	18.02%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$225.58M*	$224.68M	$908.00K*	$285.91M	78.90%*	$0.00*	$190.70M*	$577.00K	$26.66M	(m)	(m)
2019-06-30	Reported	-$17.64M*	-$18.55M	$910.00K*	$860.00K	-2050.58%*	$0.00*	-$26.90M*	$1.33M	$12.64M	(m)	(m)
2019-03-31	Reported	-$16.57M	(m)	(m)	(m)	-679.29%	$70.00K	-$25.62M	$553.00K	$12.02M	(m)	(m)
2018-12-31	Reported	-$11.46M	(m)	(m)	(m)	5481.34%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$22.01M*	-$22.93M	$918.00K*	$556.00K	-3958.45%*	$3.00K*	-$22.18M*	$551.00K	$13.76M	(m)	(m)
2018-06-30	Reported	-$29.34M*	-$30.27M	$928.00K*	$6.40M	-458.21%*	$15.00K*	-$52.52M*	$838.00K	$26.48M	(m)	(m)
2018-03-31	Reported	-$36.79M	(m)	(m)	(m)	-185.49%	$40.00K	-$46.77M	$533.00K	$47.70M	$14.86M	(m)
2017-12-31	Reported	-$23.8M	(m)	(m)	(m)	77.06%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$27.68M*	-$28.61M	$923.00K*	(m)	(m)	$61.00K*	-$33.96M*	$599.00K	$39.14M	$16.72M	(m)
2017-06-30	Reported	-$32.57M*	-$33.49M	$918.00K*	(m)	(m)	$71.00K*	-$32.23M*	$537.00K	$26.93M	$18.48M	(m)
2017-03-31	Reported	-$41.85M	(m)	(m)	(m)	-228.78%	$92.00K	-$85.50M	(m)	$43.58M	$14.87M	(m)
2016-12-31	Reported	-$20.84M	(m)	(m)	(m)	34.56%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$34.42M*	-$34.93M	$511.00K*	(m)	(m)	$16.00K*	-$35.22M*	(m)	$52.53M	$12.26M	(m)
2016-06-30	Reported	-$36.51M*	-$37.02M	$516.00K*	(m)	(m)	$13.00K*	-$47.88M*	(m)	$48.22M	$8.42M	(m)
2016-03-31	Reported	-$33.35M	(m)	(m)	(m)	-266.93%	$54.00K	-$43.74M	(m)	$37.00M	$8.40M	(m)
2015-12-31	Reported	$88.43M	(m)	(m)	(m)	69.47%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$33.62M*	-$33.68M	$60.00K*	(m)	(m)	$184.00K*	-$25.48M*	(m)	$23.11M	(m)	(m)
2015-06-30	Reported	-$26.44M*	-$26.69M	$246.00K*	(m)	(m)	$463.00K*	-$32.18M*	(m)	$20.77M	(m)	(m)
2015-03-31	Reported	-$26.17M	(m)	(m)	(m)	-1460.49%	$17.00K	-$23.48M	(m)	$20.86M	(m)	(m)
2014-12-31	Reported	-$3.24M	(m)	(m)	(m)	-15.10%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$39.81M*	-$40.34M	$526.00K*	(m)	(m)	$7.00K*	-$21.19M*	(m)	$24.11M	(m)	(m)
2014-06-30	Reported	-$25.56M*	-$26.11M	$554.00K*	(m)	(m)	$11.00K*	-$19.66M*	(m)	$21.19M	(m)	(m)
2014-03-31	Reported	-$29.83M	(m)	(m)	(m)	-10768.23%	$28.00K	-$30.32M	(m)	$23.95M	(m)	(m)
2013-12-31	Reported	-$16.31M	(m)	(m)	(m)	-1156.52%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$30.64M*	-$31.22M	$576.00K*	(m)	(m)	$268.00K*	-$23.93M*	(m)	$25.40M	(m)	(m)
2013-06-30	Reported	-$27.80M*	-$28.62M	$825.00K*	(m)	(m)	$399.00K*	-$21.13M*	(m)	$23.69M	(m)	(m)
2013-03-31	Reported	-$24.76M	(m)	(m)	(m)	-6878.33%	$839.00K	-$24.27M	(m)	$20.33M	(m)	(m)
2012-12-31	Reported	-$23.58M	(m)	(m)	(m)	-10814.68%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$28.00M*	-$29.06M	$1.05M*	(m)	(m)	$50.00K*	-$25.07M*	(m)	$19.19M	(m)	(m)
2012-06-30	Reported	-$24.39M*	-$25.48M	$1.09M*	(m)	(m)	$95.00K*	-$21.96M*	(m)	$19.36M	(m)	(m)
2012-03-31	Reported	-$28.26M	(m)	(m)	(m)	-9419.33%	$234.00K	-$27.00M	(m)	$23.04M	(m)	(m)
2011-12-31	Reported	-$32.21M	(m)	(m)	(m)	-9389.80%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$24.51M*	-$25.69M	$1.18M*	(m)	(m)	$182.00K*	-$20.22M*	(m)	$19.66M	(m)	$0.00
2011-06-30	Reported	-$24.66M*	-$25.93M	$1.26M*	(m)	(m)	$308.00K*	-$23.69M*	(m)	$20.14M	(m)	(m)
2011-03-31	Reported	-$27.83M	(m)	(m)	(m)	-4669.30%	$507.00K	-$21.54M	(m)	$23.92M	(m)	(m)
2010-12-31	Reported	-$21.11M	(m)	(m)	(m)	-1685.00%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$22.92M*	-$24.25M	$1.34M*	(m)	(m)	$316.00K*	-$18.63M*	(m)	$18.94M	(m)	-$26.00K
2010-06-30	Reported	(m)	-$24.07M	(m)	(m)	(m)	(m)	(m)	(m)	$20.24M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$48.29M	(m)	(m)	(m)	-96.96%	$0.00	-$67.85M	$274.00K	$61.12M	$37.32M	(m)
2024-12-31	Reported	-$196.58M	(m)	(m)	(m)	-3275.84%	$1.03M	-$178.78M	$616.00K	$84.48M	$143.10M	$0.00
2023-12-31	Reported	-$171.2M	(m)	(m)	(m)	-15423.06%	$470.00K	-$161.90M	$85.00K	$58.89M	$113.98M	$0.00
2022-12-31	Reported	-$100.33M	(m)	(m)	(m)	(m)	$1.33M	-$88.85M	$0.00	$52.82M	$48.08M	$0.00
2021-12-31	Reported	-$86.8M	(m)	(m)	(m)	(m)	$1.22M	-$87.02M	$0.00	$55.05M	$32.34M	$0.00
2020-12-31	Reported	-$44.87M	(m)	(m)	(m)	-191.70%	$87.00K	-$142.97M	$1.93M	$153.62M	(m)	(m)
2020-09-30	Rolling	(m)	-$87.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	$50.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	$96.48M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	$145.1M	(m)	(m)	(m)	448.79%	$70.00K	$113.81M	$3.23M	$91.92M	(m)	(m)
2019-12-31	Rolling	(m)	$141.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	$176.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$71.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$83.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$99.6M	(m)	(m)	(m)	-374.66%	$95.00K	-$148.61M	$2.49M	$100.24M	(m)	(m)
2018-12-31	Rolling	(m)	-$103.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$119.93M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$125.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$128.82M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$127.23M	(m)	(m)	(m)	-800.66%	$228.00K	-$185.39M	$1.90M	$152.22M	(m)	(m)
2017-12-31	Rolling	(m)	-$130.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$132.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$139.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$142.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$125.12M	(m)	(m)	(m)	(m)	$231.00K	-$175.63M	$0.00	$163.97M	(m)	$0.00
2016-12-31	Rolling	(m)	-$137.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$17.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$16.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$5.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	$2.2M	(m)	(m)	(m)	1.69%	$910.00K	$184.78M	(m)	$95.19M	(m)	$0.00
2015-12-31	Rolling	(m)	$1.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$90.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$97.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$96.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$98.44M	(m)	(m)	(m)	-430.73%	$80.00K	-$75.62M	(m)	$89.28M	(m)	-$70.00K
2014-12-31	Rolling	(m)	-$100.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$113.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$104.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$107.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$99.51M	(m)	(m)	(m)	-4478.31%	$1.72M	-$91.08M	(m)	$89.68M	(m)	$0.00
2013-12-31	Rolling	(m)	-$102.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$109.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$107.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$104.59M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$104.23M	(m)	(m)	(m)	-9570.71%	$492.00K	-$94.46M	(m)	$82.57M	(m)	$0.00
2012-12-31	Rolling	(m)	-$108.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$117.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	-$113.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$114.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$109.21M	(m)	(m)	(m)	-5906.33%	$1.21M	-$87.94M	(m)	$91.83M	(m)	$0.00
2011-12-31	Rolling	(m)	-$114.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$90.32M	(m)	(m)	(m)	-1840.34%	$1.13M	-$82.37M	(m)	$78.52M	(m)	-$26.00K
2009-12-31	Reported	-$83.8M	(m)	(m)	(m)	-783.15%	$369.00K	-$89.02M	(m)	$81.24M	(m)	-$102.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
GERON CORP (GERN)	United States	$0.803B	-12.14
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78